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www.jpaAbstract: The Visual Analogue Scale (VAS), Numeric Rating Scale (NRS), and Pain Severity sub-
scale of the Brief Pain Inventory (BPI-PS) are the most frequently used instruments to measure
pain intensity in low back pain. However, their measurement properties in this population have
not been reviewed systematically. The goal of this study was to provide such systematic evi-
dence synthesis. Six electronic sources (MEDLINE, EMBASE, CINAHL, PsycINFO, SportDiscus, Goo-
gle Scholar) were searched (July 2017). Studies assessing any measurement property in patients
with nonspecific low back pain were included. Two reviewers independently screened articles
and assessed risk of bias using the COSMIN checklist. For each measurement property, evidence
quality was rated as high, moderate, low, or very low (GRADE approach) and results were classi-
fied as sufficient, insufficient, or inconsistent. Ten studies assessed the VAS, 13 the NRS, 4 the
BPI-PS. The 3 instruments displayed low or very low quality evidence for content validity. High-
quality evidence was only available for NRS insufficient measurement error. Moderate evidence
was available for NRS inconsistent responsiveness, BPI-PS sufficient structural validity and inter-
nal consistency, and BPI-PS inconsistent construct validity. All VAS measurement properties were
underpinned by no, low, or very low quality evidence; likewise, the other measurement proper-
ties of NRS and BPI-PS.
Perspectives: Despite their broad use, there is no evidence clearly suggesting that one among
VAS, NRS, and BPI-PS has superior measurement properties in low back pain. Future adequate quality
head-to-head comparisons are needed and priority should be given to assessing content validity,
test-retest reliability, measurement error, and responsiveness.
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Measurement Properties of the VAS, NRS, and BPI-PS in LBPL
ow back pain (LBP) is the most disabling health
condition worldwide.33 Measuring the impact of
LBP on patients’ lives is fundamental to monitor-
ing clinical management and to study the (cost) effec-
tiveness of treatments.4 Patients with LBP have
indicated that the most important domains to be mea-
sured are physical functional activities, pain reduction,
quality of life, enjoyment of life, emotional well-being,
and fatigue.9,43,103 A core outcome set initiative (involv-
ing patients) aimed at standardizing measurement for
LBP identified 4 core outcome domains for clinical trials:
physical functioning, pain intensity, health-related qual-
ity of life, and number of deaths.9 Among these
domains, pain intensity is the most frequently assessed
in LBP clinical trials.31
Pain intensity, defined as “how much a patient
hurts, reflecting the overall magnitude of the pain
experience,”102 is the pain domain that ranked the
highest among various pain domains (eg, pain qual-
ity, temporal aspects of pain, pain behavior, and pain
interference) in consensus exercises to establish core
outcome domains for LBP9 and other pain condi-
tions.53,77 The visual analogue scale (VAS) is the
patient-reported outcome measure (PROM) most fre-
quently used to measure pain intensity in LBP trials,
followed by the numeric rating scale (NRS) and the
Pain Severity subscale of the Brief Pain Inventory
(BPI-PS).7,31 Recent consensus-based studies have
shown that researchers and clinicians prefer the NRS
over other instruments to measure pain intensity in
LBP.13,17,22,24 However, this choice has not been
explicitly based on its measurement properties and
feasibility.5,85
The NRS, VAS, and BPI-PS are highly feasible for
clinical research and practice, providing very little
burden to professionals and patients.39 Various
reviews have attempted to synthesize their measure-
ment properties in samples of patients with
pain.6,42,47,52,86,94,108 All these reviews focused on
chronic pain broadly and two of them solely focused
in children and adolescents.6,94 In recent years, the
COnsensus-based Standards for the selection of
health Measurement INstruments (COSMIN) initiative
has developed tools that allow researchers to con-
duct high quality systematic reviews on the measure-
ment properties of PROMs.72,73,84,100 Given that these
existing reviews predated the COSMIN guidance
,42,47,52,86,108 key methodologic steps (eg, quality
assessment of the studies, formulation of evidence
synthesis and findings taking the quality of the stud-
ies into account, definition of the methods to com-
bine study results90,105) could not be included.
Therefore, it is timely to adopt the most recent meth-
odologic advancements in a systematic review on
PROMs for pain intensity.
The objective of this study was to systematically
synthesize the evidence on the measurement proper-
ties of the VAS, NRS, and BPI-PS in adult patients
with LBP. This review was conducted within an inter-
national collaboration aimed at developing a core
outcome measurement set for LBP12 and informed a
246 The Journal of PainDelphi study to reach consensus on which core out-
come measurement instrument(s) to endorse for pain
intensity in LBP clinical trials.8 For this reason, in con-
trast with previous reviews that had a more generic
focus on various pain conditions,6,42,47,52,86,94,108 this
review focused solely on studies in patients with LBP,
following the approach adopted in Cochrane reviews
of randomized clinical trials on the effectiveness of
interventions in patients with LBP.32Methods
This systematic review was conducted according to
COSMIN guidance84 and reported according to the
PRISMA statement.71 Its protocol was registered in




The VAS is a self-reported scale consisting of a hori-
zontal or vertical line, usually 10 cm long (100 mm)
anchored at the extremes by 2 verbal descriptors refer-
ring to the pain status.45 An introductory question (with
or without a time recall period) asks the patient to tick
the line on the point that best refers to his or her pain.
The introductory question, the recall period, and the
content of the external verbal descriptors vary in the
literature.39
The NRS is a numbered version of the VAS in which
the patient can select one number that best describes
the pain.23 Like in the VAS, the NRS introductory ques-
tion, time recall period and verbal descriptors can vary;
the most frequently used version is the 11-point (0-10)
NRS.39
The BPI-PS consists of four 11-point NRSs, two of
which asking the patient to rate the pain at its worst
and least in the last 24 hours, and the other two asking
about pain on the average and right now.15 For each
NRS, the verbal descriptors are no pain and pain as bad
as you can imagine, and this questionnaire is usually
administered as part of the BPI, which includes other 11
pain-related questions (seven of which belonging to the
pain interference subscale).15Literature Search
Data Sources and Searches
MEDLINE (through the interface PubMed), EMBASE
(Embase.com), CINAHL (EBSCOhost), PsycINFO (EBSCO-
host), and SportDiscus (EBSCOhost) were last searched
on July 25, 2017. The search strategy consisted of 3
groups of search terms combined with the Boolean
operator AND 1) PROMs names, 2) LBP, 3) measurement
properties. A validated search filter for retrieving stud-
ies on measurement properties in PubMed was used98;
the same filter was adapted for all the other databases
(Appendix 1). No restrictions for language or time were
adopted in the search strategies. Google Scholar was
also searched (last on July 28, 2017) with the full names
Chiarotto et al The Journal of Pain 247of the PROMs and the first 100 hits for each PROM were
screened for inclusion. Citation tracking of the eligible
studies was carried out by consulting the database Web
of Science and by checking their references.Study Selection
Any study on 1 or more of the 3 instruments was
included if it assessed ≥1 of the 9 measurement proper-
ties identified by the COSMIN taxonomy: internal consis-
tency, test-retest reliability, measurement error, content
validity, structural validity, construct validity/hypotheses
testing, cross-cultural validity, criterion validity, and
responsiveness.73 Studies presenting the development
of the PROMs were included for the assessment of con-
tent validity.100 Other studies were considered eligible
for the assessment of content validity if they were full-
text original articles, including adult patients (>18 years
of age) with nonspecific LBP67 and/or professionals (eg,
researchers, clinicians) to assess the relevance, compre-
hensiveness, or comprehensibility of the content of ≥ 1
of the 3 PROMs.100 Studies on all the other measure-
ment properties were included if they were full-text
articles presenting results for adult patients with non-
specific LBP. Studies in populations that also included
patients with specific LBP or patients with pain locations
different from the lower back were included only if
≥75% of the total sample was classified as having non-
specific LBP or if results were presented separately for
the group with nonspecific LBP.54 Studies that used the
PROMs as outcome measurement instruments, or in
which the PROMs were used in a validation studies of
other instruments, were excluded.84
Inclusion criteria were applied by 2 reviewers (A.C.
and L.M.) independently to the titles and abstracts of
the hits retrieved with the searches. Potentially eligible
full texts were screened independently by the same 2
reviewers. Consensus on inclusion was sought between
reviewers and, in case of disagreement, a third reviewer
(R.O.) made decisions.Evaluation of the Measurement
Properties
After retrieving the available evidence, COSMIN guid-
ance for systematic reviews of PROMs recommends
assessment of measurement properties in the following
order: 1) content validity, 2) internal structure (ie, struc-
tural validity, internal consistency, and cross-cultural
validity), and 3) the remaining properties (ie, test-retest
reliability, measurement error, criterion validity, con-
struct validity, responsiveness).84 For each measurement
property, 3 phases are included in the assessment. First,
the risk of bias of each single study on a measurement
property is assessed. Second, the results of each single
study on a measurement property are rated against
criteria for sufficient measurement properties. Third,
the results from all studies on a measurement property
are summarized and the quality of evidence is graded.
Each phase is described in more detail in the following
sections.Risk of Bias Assessment and Data Extraction
The risk of bias of the included studies was assessed
with the COSMIN Risk of Bias checklist.72 Risk of bias
refers to the methodologic quality of the studies. The
COSMIN checklist contains a box for each measurement
property and boxes to assess the PROM development
quality.100 Each box is rated on a 4-point rating scale:
very good, adequate, doubtful, or inadequate. For the
development study, total quality scores were
determined separately for the 2 main parts of the study:
concept elicitation study and cognitive interview(s) with
patients. For the content validity studies, the study
quality for the 3 main aspects of content validity (ie, rel-
evance, comprehensiveness, comprehensibility) was
assessed separately. A total rating was obtained for
each part by taking the lowest rating among the
standards (ie, worst score counts).99 Two reviewers
(A.C. and C.T.) assessed PROM development quality and
the risk of bias of original content validity studies inde-
pendently and achieved consensus in a face-to-face
meeting.
A similar 4-point rating scale and worst score counts
method were also used for assessing the risk of bias for
studies on the other measurement properties72 and a
total quality rating was determined for the studies on
each measurement property in each study. Two
reviewers (A.C. and L.M.) assessed the risk indepen-
dently and achieved consensus in a video conference.
For every study, data was extracted on patient charac-
teristics and results by 1 reviewer (A.C.) and checked for
accuracy by a second reviewer (L.M.).Evidence Synthesis
Evidence synthesis was performed separately for each
measurement property.84,100 For content validity, the
results of the studies (including PROM development)
were rated by 2 reviewers (A.C. and C.T.) independently
according to 10 established criteria: 5 on relevance, 1 on
comprehensiveness, and 4 on comprehensibility.100 Each
criterion could be rated as sufficient (+), insufficient (−),
or indeterminate (?). The same criteria were also applied
by 2 reviewers (A.C. and C.T.) to the content of the
PROM itself100; a specific version of the VAS and NRS
was used for this assessment, with the introductory
question, recall period, and external descriptors as rec-
ommended in a recent consensus study (Appendix 2).8
An overall sufficient (+), insufficient (−), or inconsistent
(§) rating was determined for relevance, comprehen-
siveness, and comprehensibility of each PROM by jointly
assessing all results and reviewers’ ratings on the same
PROM. More detailed information on this assessment
can be found in the COSMIN user manual on assessing
the content validity of PROMs (available at: www.cos
min.nl).
For the other measurement properties, the results
were rated according to the consensus-based criteria
proposed by Prinsen et al85 (Appendix 3). For measure-
ment error, consensus-based minimal important change
values75 were used to judge the relative magnitude of
248 The Journal of Pain Measurement Properties of the VAS, NRS, and BPI-PS in LBPthe smallest detectable change. For construct validity
and responsiveness, the review team formulated a set of
a priori hypotheses against which to evaluate the results
of studies. For both properties, correlations were
expected to be:
- ≥ .60 with other pain intensity instruments;
- <.60 and ≥ .30 with instruments measuring related but dis-
similar constructs (eg, pain behavior, physical functioning);
and
- <.30 with instruments measuring unrelated constructs.
These hypotheses were based on the results of a sys-
tematic review on physical functioning PROMs for
LBP.10 Two additional hypotheses were formulated for
responsiveness:
- the area under the curve to discriminate between improved
and not improved/deteriorated patients had to be ≥ .70;
- effect sizes and standardized response means for improved
patients had to be ≥ .50 larger than those for not
improved/deteriorated patients; the effect size referred to
the mean difference divided by the baseline standard devi-
ation, whereas the standardized response mean referred
to mean differences divided by the standard deviation of
the difference.20
For construct validity and responsiveness, an overall
sufficient (+), insufficient (−), or inconsistent (§) rating
was determined by counting the number of results that
met the hypotheses across all studies.84 For the other
measurement properties, an overall rating was deter-
mined by lumping together the scoring of each individ-
ual study; if ≥ 75% of the studies displayed the same
scoring, that scoring became the overall rating (+ or −),
whereas if <75% of studies displayed the same scoring,
the overall rating became inconsistent (§).84
The quality of evidence for each measurement prop-
erty was rated according to the Grading of Recommen-
dations, Assessment, Development and Evaluation
(GRADE) approach,37 adapted for this type of review,
into high, moderate, low, or very low.84,100 High-quality
evidence indicates that further research is very unlikely
to change the confidence in study results; moderate
indicates that is likely that further research will have an
important impact on study results and may change
them; low suggests that further research is very likely to
have an important impact on study results and is likely
to change them; very low means that any result is very
uncertain.37 For content validity, the evidence quality
could be downgraded because of risk of bias and incon-
sistency of results and indirectness, as outlined else-
where.100 For the other measurement properties, risk of
bias, imprecision, inconsistency, and indirectness were
taken into account to rate the evidence quality.84 The
concepts of risk of bias, imprecision, inconsistency, and
indirectness were taken from the GRADE approach.37
Risk of bias refers to limitations in the methodologic
quality of the eligible studies, imprecision refers to a
low total number of patients included in the studies,
inconsistency refers to unexplained heterogeneity of
studies’ results, and indirectness refers to the extent towhich the study characteristics met the review inclusion
criteria.32
Rating the quality of evidence for content validity was
performed by giving more weight to original content
validity studies over PROM development and reviewers’
rating, as explained elsewhere (Appendix 4).100 Thus, if
there were no content validity and no PROM develop-
ment studies (or if the PROM development was of inad-
equate quality), the overall rating corresponded to the
reviewers’ rating and quality of evidence was labelled
as very low.100 For the other measurement properties,
downgrading was done for risk of bias of 1 level if there
was only 1 adequate quality study, 2 levels if there were
only doubtful or inadequate studies; imprecision of 1
level if the total patient sample was <100 and 2 levels if
<50; inconsistency of 1 level if ≥ 75% of studies results
were not all sufficient (+), insufficient (−), or inconsis-
tent (§); indirectness of one level if ≥1 study did not
specifically address the construct (pain intensity) or the
target population (adult patients with nonspecific LBP)
of this review (Appendix 4).11Results
Among 10,719 records retrieved, 23 full-text articles
were included, 5 of which retrieved through citation
tracking (Fig. 1). Of 45 potentially eligible articles
retrieved in the databases, 27 were excluded: 5 did
not present results separately for patients with non-
specific LBP,1,57,58,93,101 9 did not aim to assess any
measurement property,18,27,28,34,35,40,48,49,92 8 did not
report clearly if patients with nonspecific LBP were
included,25,26,38,61,66,78,83,89 and one each was
excluded for the following reasons: the VAS adminis-
tered over the phone,46 the VAS completed by a tes-
ter,74 assessed patients with experimental pain,82
assessed only patients with specific LBP,87 and focus
on other instruments.109
Three of the included full-text articles reported infor-
mation on the BPI-PS development15,16,19 and the other
20 included 22 original studies (2 articles included 2
studies each36,59) on the measurement properties of the
3 PROMs. The VAS was assessed in 10 studies, the NRS in
13, and the BPI-PS in 4. Four studies assessed >1 PROM
for the same patient group36,88,95 (Table 1).
VAS
A 100-mm VAS was used in all 10 studies; introductory
statement, time recall period, and external verbal
descriptors varied (Table 1). One study assessed content
validity,88 2 test-retest reliability,64,80 2 measurement
error,76,80 2 construct validity,29,95 and 4 responsive-
ness.3,36,91 Patients’ characteristics of each study are pre-
sented in Table 1 and their results in Tables 2 to 4.
Content Validity
None of the studies retrieved described the develop-
ment of the VAS as a pain intensity instrument. Robin-
son-Paap et al88 assessed VAS relevance and
comprehensiveness with adequate quality; the same
Figure 1. Flow chart of results of search strategy and selection of records.
Chiarotto et al The Journal of Pain 249study also assessed NRS and BPI-PS. Three main themes
were identified by patients with LBP on the instruments:
1) perception that it may not even be possible to mea-
sure pain in a meaningful way, 2) difficulty in finding
appropriate experiences as referents, and 3) difficulty
with averaging pain. A few specifications for each
theme are presented here.
1) Example: “At the end of the day a single line is really not
going to tell what I’ m actually feeling.” Three more spe-
cific subthemes were identified:
a Pain measurement is influenced by other things other than
pain.
b The numbers used to rate pain do not have an absolute
meaning.
c Preference for pain intensity ratings in the middle of the
scale.
2) This theme included 2 subthemes:
a Some patients used their prior LBP episodes as compara-
tors; others did not use a comparator experience at all;
rather, they thought of pain based on how much medica-
tion they took in a particular day.
b Several patients thought that anchoring the lower end to
no pain was not appropriate because they always experi-
ence some pain. Some patients expressed that they would
not use the highest numbers on the scale because doing sowould indicate a lack of ability to cope with the pain. The
suggestions of average, normal, or usual as alternative
anchors also emerged.
3) Generating a number to represent average pain over a
given time period was not an intuitive task. The longer the
time period over which to average, the more difficulty par-
ticipants had.
Relevance and comprehensiveness were rated as
insufficient based on these results; the reviewers rated
relevance, comprehensiveness, and comprehensibility of
the VAS as sufficient. Low-quality evidence was found
for inconsistent findings for relevance and comprehen-
siveness, owing to inconsistency and indirectness,
because the only eligible study did not specifically focus
on the pain intensity construct, but on pain in general
without referring to a specific aspect such as intensity
(Table 5). Very low-quality evidence was found for suffi-
cient comprehensibility (Table 5).Internal Structure
Structural validity and internal consistency are not
applicable to the VAS and NRS because these measures
are single-item instruments. No studies were found on
cross-cultural validity.
Table 1. Characteristics of the Studies Included in This Systematic Review
PROM(S) REFERENCE LANGUAGE
(COUNTRY)





















Robinson-Papp88 English (US) Focus groups
and individual
interviews
>2 months with or
without leg pain

















Intensity Pain as bad as
it could be
92 49 46§ 13 10§ 10 years
11-point NRS 6.3 § 2.3
VAS, NRS Grotle36 Norwegian Longitudinal <3 weeks Responsiveness 100-mm VAS 39 § 23 For the time
being
Pain as bad as
it could be
54 73 38§ 10 10§ 7 days
11-point NRS 6.8 § 1.8 During the last
week
VAS, NRS Grotle36 Norwegian Longitudinal >3 months Responsiveness 100-mm VAS 34 § 23 For the time
being
Pain as bad as
it could be
50 62 40§ 9 2 § 2 years
11-point NRS 6.1 § 2.4 During the last
week
Three VASs Love64 English
(Australia)







10-cm VAS At its worst
10-cm VAS At its best
VAS Beurskens3 Dutch RCT >6 weeks Responsiveness 100-mm VAS Average sever-
ity during last
week
81 46 41§ 10 24 weeks
(median)


















Responsiveness 100-mm VAS 77 § 14 Intensity Extreme pain 639 62 53§ 13 11§ 11 years




































































10-cm VAS 39 § 9 Average over
the lumbosa-
cral area
Extreme pain 13 69 26§ 6 1 § 1 years
VAS Fishbain29 English (US) Longitudinal >6 months as pri-
mary complaint
Construct validity 100-mm v-VAS 62 § 32 Current Unbearable
pain
236
Four NRSs Hush44 English
(Australia)
Focus groups Persistent or recur-
rent LBP, or recov-
ery from previous
LBP
Content validity 11-point NRS At its worst in
the past 24 h
Pain as bad as
you can
imagine




At its least in
the past 24 h
On the average
Right now












131 42 34§ 11 66% at <6
weeks
Best level dur-
ing last 24 h
Worst level dur-
ing last 24 h






11-point NRS 7.5 § 2.0 Lower back Worst imagin-
able pain
1349 68 54§ 15 9 § 8 years
NRS Pengel81 English
(Australia)
RCT >6 weeks and<3
months




156 56 49§ 16
NRSz Lauridsen59 Danish Longitudinal With or without leg
pain






94 53 44 73%≤30 days,
rest>30 days













































NRSx Lauridsen59 Danish Longitudinal With or without leg
pain





97 54 47 12%
≤30 days,
rest 30 days
NRS{ Van der Roer104 Dutch RCT Measurement
error
11-point NRS 6.4 § 1.8 Intensity Very severe
pain
114








147 66 46 37% at ≤ 6
months






11-point NRS 5.0 § 2.6 Intensity Worst imagin-
able pain
48 67 52 6 years (mean)




BPI-PS NA NA 131 50 46 § 14





BPI-PS 7.0 § 1.8 NA NA 440 8 55 10 § 7 days
BPI-PS Whynes106 English (UK) RCT Responsiveness BPI-PS 8.1 § 3.0 NA NA 37
Abbreviations: SD, standard deviation; v-VAS, vertical VAS; RCT, randomized controlled trial; ODI, Oswestry Disability Index; NA, not applicable.
Note. Empty cells reflect data not assessed.
*The low anchor was always no pain.
yThe average of the 3 ratings was used to represent the patient’s overall pain intensity.
zThis study refers to primary care patients.
xThis study refers to secondary care patients.
{Measurement error was calculated on unchanged patients but characteristics of those patients alone were not presented.









































Table 2. Test-Retest Reliability and Measurement Error of Pain Intensity Instruments in Patients With LBP
PROM(S) REFERENCE PAIN CONSTRUCT TEST-RETEST RELIABILITY MEASUREMENT ERROR




Three VASs Love64 Experienced now 63 Doubtful Some days .77y
At its worst .49y
At its best .57y
VAS Ostelo76 Current intensity 176 Doubtful Maximum 24 hours 13 (12-15, 13)z 36 (32-41, 36)z
VAS Paungmali80 Average over the lumbosacral area 13 Doubtful 48 hours .90z 13 Inadequate 48 hours .1 (—, 1)z .3 (—, 3)x
Three NRSs* Childs14 Current, best, and worst level during last 24 h 41 Adequate 1 week .61 (.30-.77)z 41 Adequate 1 week 1.0 (—, 10)z 2.8 (—, 28)x
NRS Kovacs56 Lower back 209{ Adequate 12 weeks 1.3 (—, 13)x 3.5 (3.2-3.8, 35)
NRS van der Roer104 Intensity 52k Doubtful 12 weeks 1.7 (—, 17)x 4.7 (3.3-8.0, 47)
62k 1.6 (—, 16)x 4.5 (3.4-6.7, 45)
NRS Lauridsen60 Intensity over past week 55 Adequate 1 week 1.0 (—, 10)x 2.8 (—, 28)
NRS Maughan69 Intensity 25 Adequate 5 weeks .92y 25 Adequate 5 weeks .9 (—, 9)z 2.4 (—, 24)z
Abbreviations: ICC, intraclass correlation coefficient; SEM, standard error of measurement; SDC, smallest detectable change.
Note. Empty cells represent aspects not assessed.
* The average of the 3 ratings was used to represent the patient’s overall pain intensity.
y This value represents a Pearson product-moment correlation and not an intraclass correlation coefficient.
z It is unclear if ICCconsistency SEMconsistency, or ICCagreement, SEMagreement was used.
x This SEM or SDC was not reported in the article but it was calculated from the available data (SDC was calculated as SEM xx2£ 1.96).
{ The sample size for the measurement error of the NRS for LBP was not reported in the article; therefore, this number includes also patients with leg pain.
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Only 1 study80 presented results that could be rated
for test-retest reliability (Table 2), providing low-quality
evidence (owing to risk of bias and imprecision) of suffi-
cient reliability (Table 5). Owing to risk of bias and
inconsistency of results across studies (Table 2), very-low
quality evidence of inconsistent findings was found for
measurement error (Table 5).
Results on hypothesis testing for construct validity
were inconsistent across studies (Table 3), providing
low-quality evidence (owing to risk of bias and inconsis-
tency) on this measurement property (Table 5). The
results of 4 studies were tested against our hypotheses
for responsiveness (Table 4), providing low-quality evi-
dence (owing to risk of bias and inconsistency of results)
of inconsistent results for this measurement property
(Table 5).NRS
The 11-point NRS was used in all 13 studies; external
descriptors varied slightly, whereas construct and recall
period in the introductory statement varied more widely
(Table 1). One study14 administered 3 NRSs referring to
current, best, and worst pain over the last 24 hours and
took the average of the 3 scores in the analyses. Two
studies evaluated content validity,44,88 2 test-retest reli-
ability,14,69 5 measurement error,14,56,60,69,104 1 construct
validity,95 and 8 responsiveness14,36,56,59,69,81; 4 studies
assessed the NRS in conjunction with other pain intensity
instruments.36,88,95
Content Validity
No studies presenting the NRS development were
found. Robinson-Paap et al88 analyzed the NRS together
with the VAS and BPI-PS, displaying the same results for
all the instruments, as summarized for the VAS results.
Hush et al44 assessed the relevance and comprehensive-
ness of 4 NRS versions in a study of adequate quality.
The majority of patients included in this study (ie,
>50%) expressed the opinion that the NRS does not
adequately capture the complexity of their personal
experience of pain. Two themes emerged: 1) the mean-
ing attributed to the pain score and 2) the time-frame
of measurement. Regarding the first theme, participants
reported that their score reflects many aspects of the
pain experience, other than the sensory component of
pain; another common view was that NRS scores are
highly dependent on individual experiences of pain that
can determine the benchmark used by a patient to rate
the pain. Regarding the second theme, a majority
believed that the NRS versions assessing pain in the past
24 hours or right now were unlikely to capture improve-
ments because of symptom fluctuation.
These results, taken together with the reviewers’ rat-
ings on the NRS to measure pain intensity in LBP, pro-
vided inconsistent results based on low quality
evidence (owing to inconsistency and indirectness;
Table 5).
Table 4. Responsiveness (Hypotheses Testing) of Pain Intensity Instruments in Patients With LBP








ESS* OR SRMSy (95% CI) CORRELATIONS
WITH CHANGES IN
OTHER INSTRUMENTS
VAS, NRS Grotle36 Doubtful 4 weeks 6-point GPES from
worse to completely
recovered
VAS For the time being 42 74 better,
26 same
.59 91 (83- 100) .7 (.4 to 1.0) SRM overall;
1.6 (1.1 to 2.0) SRM bet-
ter;






NRS During last week 45 76 better
24 same
.76 93 (86 to 100) 1.1 (.8 to 1.5) SRM overall;
2.0 (1.4 to 2.6) SRM bet-
ter;






VAS, NRS Grotle36 Doubtful 3 months 6-point GPES from
worse to completely
recovered
VAS For the time being 33 48 better,
52 same
.24 71 (54 to 88) -.1 (.4 to 1.0) SRM overall;
.4 (-.2 to .9) SRM better;






NRS During last week 39 49 better,
51 same
.52 82 (67 to 96) .3 (.0 to .6) SRM overall;
1.1 (.4 to 1.7) SRM better;






VAS Beurskens3 Adequate 5 weeks 7-point GPES from
completely recovered
to vastly worsened





91 1.6 SRM better;
.1 SRM same
VAS Sheldon91 Doubtful 12 weeks 5-point PGART from
excellent to none
VAS Lower back intensity 639 .68-.74x 88 (85 to 90) 1.8-2.6 ES overallx .66-.70 to
RMDQx
NRS Pengel81 Doubtful 6 weeks 11-point GPES from
vastly worse to
completely recovered
NRS Average over past
week
156 .50 1.3 (1.2 to 1.4) ES overallz
Three NRSs{ Childs14 Doubtful 1 week 15-point RS from a great
deal worse to a very
great deal betterk






72 (62 to 81) .9 SRM overall;
1.4 SRM better;
.5 SRM same
4 weeks 82 better,
13 same,
4 worse
92 (86 to 97) 1.2 SRM overall;
1.5 SRM better;
.6 SRM same
NRS Lauridsen59 Adequate 8 weeks 7-point GPES from much
better to much worse,
and NRS to score pain
change importance




65 in LBP only 1.5 (1.2 to 1.8) SRM bet-
ter;
.8 (.3 to 1.3) SRM same
NRS Lauridsen59 Adequate 8 weeks NRS 59** 62 in LBP only
































ESS* OR SRMSy (95% CI) CORRELATIONS
WITH CHANGES IN
OTHER INSTRUMENTS
7-point GPES from much
better to much worse,
and NRS to score pain
change importance




.9 (.4 to 1.3) SRM better;
.2 (-.1 to .5) SRM same
NRS Kovacs56 Doubtful 12 weeks 4-point RS from
completely recovered
to worsened









NRS Maughan69 Doubtful 5 weeks 7-poing GPES from
completely recovered
to vastly worsened
NRS Intensity 48 48 better
52 same
50












Abbreviations: AUC, area under the ROC curve; SRM, standardized response mean; GPES, global perceived effect scale; RMDQ, Roland Morris Disability Questionnaire; ODI, Oswestry Disability Index; DRI, Disability Rating Index; SF36-PF,
physical functioning subscale of the Short Form 36; PGART, patient global assessment of response to therapy; RS, rating scale; BPI-PI, pain interference subscale of the BPI; NA , not applicable; EQ5D-US, utility score of the EuroQol-5D;
EQ5D-VAS, VAS of the EuroQol-5D.
Note. Empty cells indicate not available or not assessed data.
* ESs were calculated by dividing the mean change by the baseline standard deviation.
y SRMs were calculated by dividing the mean change by its standard deviation.
z In this case, an 84% CI was presented.
x This is the range of correlations or ESs found in the 3 separate arms of this study (ie, etoricoxib 60 mg, etoricoxib 90 mg, placebo).
{ The average of the 3 ratings was used to represent the patient’s overall pain intensity.
k These ESs or SRMs were not reported in the article but calculated from the available data.
# Primary care patients.
** Secondary care patients.









































Table 5. Evidence Synthesis on Measurement Properties of Pain Intensity Instruments in Patients
with LBP
MEASUREMENT PROPERTIES VAS NRS BPI-PS
Content validity Relevance Rating § § §
Quality of evidence Low Low Low
Comprehensiveness Rating § § §
Quality of evidence Low Low Low
Comprehensibility Rating + + +
Quality of evidence Very low Very low Very low
Structural validity Rating NA NA +
Quality of evidence Moderate
Internal consistency Rating NA NA +
Quality of evidence Moderate
Test-retest reliability Rating + §
Quality of evidence Very Low Low
Measurement error Rating § ‒
Quality of evidence Very Low High
Construct validity Rating § § §
Quality of evidence Low Very Low Moderate
Responsiveness Rating § § §
Quality of evidence Low Moderate Very Low
Abbreviations: +, sufficient results; ‒, insufficient results; §, inconsistent results; NA, measurement property not applicable.
Note. Empty cells represent measurement properties not assessed in any study. The cross-cultural validity row is not displayed because it was not assessed in any
study.
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Structural validity and internal consistency are not
applicable to the NRS because it is a single-item scale
and no studies assessing cross-cultural validity were
retrieved.Other Measurement Properties
Low-quality evidence (owing to inconsistency and
imprecision) was found for inconsistent findings for
test-retest reliability (Tables 2 and 5). High-quality evi-
dence was found for insufficient measurement error
(Table 5) because the smallest detectable change values
in 4 adequate quality studies were greater than the pro-
posed 2-point minimal important change (Table 2).75
Very low-quality evidence from 1 study of inadequate
quality was found for inconsistent results on construct
validity (Tables 3 and 5). Seven of the 8 responsiveness
studies provided results to be rated against our hypoth-
eses (Table 4), resulting in inconsistent results based on
moderate quality evidence (owing to inconsistency;
Table 5).BPI-PS
Three studies presented information on the BPI-PS
development.15,16,19 Among the other 4 studies
(Table 1), 1 assessed content validity,88 2 internal consis-
tency,55,97 1 structural validity,97 2 construct validity55,97
and 2 responsiveness.55,106
Content Validity
The development of the BPI was rated as of doubtful
quality because it was unclear if the included patients
were representative of the target population.11 One
content validity study assessed relevance andcomprehensiveness in a study of adequate quality.88
This study also assessed the VAS and the NRS, providing
the same results for all 3 instruments, as outlined else-
where in this article. It was considered to provide indi-
rect evidence because the pain intensity construct was
not clearly specified and its negative results were in con-
trast with reviewers’ ratings; this resulted in low-quality
evidence for inconsistent findings (Table 5).Internal Structure
One study97 assessed the BPI-PS structural validity in a
study of adequate quality performing an exploratory
factor analysis on the whole BPI. The 4 BPI-PS items
loaded on the same factor explaining 12% of the total
variance and with eigenvalue equal to 1.38. The factor
loadings on this factor ranged from .61 (pain worst) to
.82 (pain least), whereas factor loadings on the first pain
interference factor were very low (between -.07 and
.16). This finding resulted in sufficient unidimensionality
based on moderate quality evidence (Table 5).
Two studies of adequate quality investigated the
internal consistency, exhibiting Cronbach’s alpha values
of .8255 and .85.97 According to the latest COSMIN guid-
ance,84 these results provide moderate quality evidence
for sufficient internal consistency (Table 5). No studies
on cross-cultural validity were retrieved.Other Measurement Properties
Test-retest reliability and measurement error of the BPI-
PS were not assessed in any study. Moderate quality evi-
dence (owing to inconsistent results across studies; Table 3)
was found for inconsistent results on construct validity
(Table 5). Responsiveness was assessed in 2 studies of inad-
equate quality (Table 4), providing very low-quality
258 The Journal of Pain Measurement Properties of the VAS, NRS, and BPI-PS in LBPevidence (owing to risk of bias and inconsistency) of
inconsistent results for this measurement property
(Table 5).Discussion
This systematic review illustrates that the quality of
evidence on the measurement properties of the VAS,
NRS, and BPI-PS in patients with LBP is clearly subopti-
mal (Table 5). The quality of evidence on content valid-
ity of all 3 instruments is low to very low. For the other
measurement properties, high-quality evidence was
only found on the insufficient measurement error of
the NRS. Moderate quality evidence was found for
inconsistent results on the NRS responsiveness, sufficient
results for BPI-PS structural validity and internal consis-
tency, and inconsistent construct validity of the BPI-PS.
For all other assessed measurement properties, the qual-
ity of evidence was low or very low (Table 5).
The NRS is most often recommended to measure pain
intensity in patients with LBP13,17,22 and in chronic pain
more generally.24 Apparently, only practical aspects
have dictated NRS recommendations in LBP so far. In a
recent international Delphi survey, researchers, clini-
cians, and patients clearly preferred the NRS over VAS
and BPI-PS to measure pain intensity in LBP clinical tri-
als.8 Several Delphi participants highlighted the VAS to
be less understandable for patients (the elderly in par-
ticular) than the NRS, time consuming to score if the
line is not exactly 100 mm long, and difficult to adminis-
ter with digital devices.8 Meanwhile, the BPI-PS was less
often chosen because it has a fee for administration and
it is less easy to administer than the other instruments.8
A previous review on a broader pain population also
concluded that the NRS was preferred over the VAS for
feasibility reasons.42 Despite these preference toward
the NRS, the VAS has been the most frequently used
pain instrument in LBP clinical trials so far31; therefore,
it is important to monitor if this pattern of use will
change in the (near) future.
Content validity is considered the first measurement
property to consider when selecting a PROM.85 Evidence
on this property could be generated by head-to-head
comparison studies where all 3 instruments are adminis-
tered and patients are asked to rate their relevance,
comprehensiveness, and comprehensibility.100 Two
studies included in this review44,88 raised issues regard-
ing the content validity of NRS and VAS, in line with the
results of a previous study in a chronic pain popula-
tion.107 If these results are replicated in future studies in
patients with LBP, the use of these instruments should
be seriously reconsidered. Because these PROMs are usu-
ally intended to measure pain intensity, future clinimet-
ric studies should consider NRS and VAS versions that
specifically refer to pain intensity in the introductory
question, as displayed in Appendix 2. Structural validity
and internal consistency of the BPI-PS were found to be
sufficient (Table 5), which is not surprising considering
that the BPI-PS items share very similar content; this
could artificially inflate its unidimensionality and
Cronbach’s alpha.This systematic review clearly showed that the NRS
measurement error is larger than the 2-point minimal
important change value commonly proposed for this
instrument in LBP (Table 3).75 This finding implies that
this PROM may not be able to distinguish the smallest
detectable changes from real changes in the measured
construct,21 which represents a serious limitation.
Whether or not VAS and BPI-PS share this problem is not
able to be determined because direct comparisons are
lacking. The measurement error of an instrument can be
decreased by increasing the number of repeated meas-
urements or items,20 as recently shown in mixed chronic
pain populations—multi-item tools displayed slightly
more reliable scores than single-item tools50,51; there-
fore, the BPI-PS may also have a smaller measurement
error than the other 2 PROMs in patients with LBP, but
this has to be tested.
The cross-cultural validity of the VAS, NRS, and BPI-PS
has not been evaluated in patients with LBP or in
broader populations with pain. Because data for
patients with LBP from different cultures are routinely
pooled in systematic reviews of clinical trials54,65,68,79
and observational studies,30,62 it is essential to exclude
substantial differential item functioning across countries
and languages. The evidence quality on construct valid-
ity and responsiveness is low (Table 5) to determine if
any instrument outperforms the others. The only study
directly comparing construct validity of VAS and NRS is
of inadequate quality.95 Two studies (of doubtful qual-
ity) comparing VAS and NRS responsiveness showed
that the NRS has larger effect sizes (and, therefore, a
better ability to capture pain intensity changes) in
patients with acute and chronic LBP,36 but this finding
requires replication. There is evidence that multiple-
item PROMs for pain do not display substantially larger
effect sizes than single-item ones in more heteroge-
neous pain conditions,48,50 but these studies did not
specifically include the BPI-PS and did not specifically
assess a range of responsiveness aspects, such as the
area under the curve and correlations with other
instruments.
Recently, the use of pain intensity scales in patients
with chronic pain has been criticized.2,63,96 More specifi-
cally, these instruments have been advocated as poten-
tial contributors to the opioid epidemic in some
countries; patients who display high pain intensity rat-
ings are those who, despite the presence of comorbid-
ities such as mental health disorders, are frequently
prescribed opioids, resulting in subsequent addic-
tion.2,96 Additionally, it has been proposed that “zero
pain is not the (only) goal” in patients with chronic
pain; rather, the main goal should be to improve (physi-
cal and psychological) functioning.2,63 This view against
the use of pain intensity scales and on the unimportance
of pain intensity is in contrast with various studies
clearly showing that decreasing pain intensity is a crucial
goal for patients living with chronic pain.9,41,43,70 There-
fore, considering the importance of pain intensity as a
core outcome domain in LBP9 and considering that the
instruments included in this review have been widely
used for decades,7,31 the lack of robust evidence
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quently used instruments for this domain is worrisome.
Nevertheless, it should be underlined that the GRADE
approach in systematic reviews on measurement proper-
ties of instruments has only recently been intro-
duced85,100 and this is the first systematic review to
adopt such an approach for all measurement properties;
therefore, reaching the high-quality evidence level will
be the goal of future research.
There is a need for adequate quality head-to-head
comparison studies on pain intensity instruments in
patients with LBP. The instruments assessed in this
review may be included in these studies alongside other
pain intensity instruments, such as Verbal Rating Scales,
the bodily pain subscale of the Short Form 36 (which
combines pain intensity measurement with pain inter-
ference), or other pain items or subscales of other
generic- or disease-specific instruments. Additionally,
other methods to assess pain intensity in patients with
pain may be considered and investigators with innova-
tive and creative ideas on how to better measure pain
intensity are certainly welcome in this field.
The main strength of this first systematic review on
the measurement properties of the 3 most frequently
used pain intensity PROMs in LBP7,31 is the use of the
most up-to-date methodology.72,73,84,100 In contrast
with previous reviews on the measurement properties
of pain intensity instruments,6,42,47,52,86,94,108 this sys-
tematic review focused on patients with LBP only; this
decision was guided by the focus of the core outcomemeasurement set for which this review was per-
formed8,9 and by the fact that there is evidence clearly
suggesting what is the best method to synthesize the
evidence on measurement properties of instruments (ie,
whether it should be synthesized in specific or generic
populations). A potential limitation is that the evidence
synthesis lumps together studies from different lan-
guages and countries and includes instruments with
(slightly) different pain constructs and high external
anchors. However, this approach is routine for pain
intensity scales in systematic reviews for LBP, splitting
studies may be equally contentious, and there is no evi-
dence on the best approach. For detailed scrutiny, lan-
guage, country and instruments’ characteristics of each
study are specified in the results (Tables 1 to 4).
In conclusion, there is currently no evidence to claim
superior measurement properties for any of the 3 com-
monly used instruments to measure pain in LBP. In our
opinion, such evidence should preferably come from
sound head-to-head comparison clinimetric studies,
with priority to be given to the assessment of content
validity, test-retest reliability, measurement error, and
responsiveness.Supplementary data
Supplementary data related to this article can be
found at https://doi.org/10.1016/j.jpain.2018.07.009.References
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